No Matches Found
No Matches Found
No Matches Found
Lactose (India) Ltd
Why is Lactose (India) falling/rising?
On 04 Dec, Lactose (India) Ltd witnessed a significant price increase of 7.81%, closing at ₹118.00, marking a notable reversal after five consecutive days of decline. This surge reflects a combination of heightened volatility, increased investor participation, and a temporary shift in trading dynamics despite the stock's challenging year-to-date performance.
Why is Lactose (India) falling/rising?
As of 17-Nov, Lactose (India) Ltd is currently priced at Rs 126.40, reflecting a 9.91% increase and strong recent performance, outperforming its sector and the Sensex in the short term. Despite a year-to-date decline of 41.45%, the stock shows signs of recovery with increased investor participation and positive trading trends.
Lactose (India) Ltd Gains 10% Today, Surpassing Sensex Amid Strong Buying Activity and Milestones
Lactose (India) Ltd is experiencing notable buying activity, with a significant stock increase today and a strong performance over the past week. The stock has shown resilience despite earlier challenges, reflecting a positive trend in the pharmaceuticals and biotechnology sector, supported by robust buyer sentiment.
Why is Lactose (India) falling/rising?
As of 14-Nov, Lactose (India) Ltd is currently priced at 115.00, reflecting a recent increase but a significant year-to-date decline of -46.73%. Despite short-term gains, the stock's volatility and reduced investor participation indicate potential caution for future performance.
Lactose (India) Reports Strong Financial Metrics Amidst Cash Flow Challenges
Lactose (India) reported strong financial metrics for the quarter ending September 2025, with record net sales of Rs 41.18 crore and a robust operating profit to interest ratio. However, challenges persist, including negative operating cash flow and a significant decline in profit after tax over the nine-month period.
Lactose (India) Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns
Lactose (India) Ltd., a Gujarat-based pharmaceutical and dairy products manufacturer, reported net profit of ₹2.16 crores for Q2 FY26, marking a 44.00% sequential increase from ₹1.50 crores in Q1 FY26 and a 6.40% rise from ₹2.03 crores in Q2 FY25. Despite the profit growth, the company's shares have struggled significantly, plunging 36.14% over the past year and trading at ₹107.70 as of November 14, 2025, reflecting investor concerns about operational efficiency and margin sustainability.
How has been the historical performance of Lactose (India)?
Lactose (India) has experienced significant growth, with net sales increasing from INR 34.96 crore in March 2021 to INR 116.40 crore in March 2025, and profit before tax improving from a loss of INR 3.27 crore to a profit of INR 6.92 crore in the same period. Total liabilities rose to INR 133.47 crore, while cash flow from operating activities showed a positive inflow of INR 2.00 crore in March 2025.
Lactose (India) Faces Evaluation Shift Amidst Declining Performance and High Debt Concerns
Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting ongoing challenges. The company's performance indicators present a mixed outlook, with concerns over its high Debt to EBITDA ratio and significant profit decline, contributing to its underperformance against broader market indices.
How has been the historical performance of Lactose (India)?
Lactose (India) has demonstrated significant financial growth, with net sales increasing from 34.96 Cr in Mar'21 to 116.40 Cr in Mar'25, and profit before tax improving from a loss to 6.92 Cr in the same period. Total assets rose to 133.47 Cr, while cash flow from operations remained stable with a net inflow of 2.00 Cr in Mar'25.
Why is Lactose (India) falling/rising?
As of 07-Nov, Lactose (India) Ltd's stock price is Rs 110.65, down 2.21%, with a year-to-date decline of 48.75%. The stock is underperforming its sector and the benchmark Sensex, indicating a bearish trend and decreased investor interest.
How has been the historical performance of Lactose (India)?
Lactose (India) has shown steady growth in net sales, increasing from INR 34.96 crore in March 2021 to INR 116.40 crore in March 2025, despite rising raw material costs impacting profitability. The company recovered from losses to achieve a profit before tax of INR 6.92 crore in March 2025, with total assets and liabilities both rising to INR 133.47 crore.
Lactose (India) Ltd Forms Golden Cross, Signaling Potential Bullish Breakout
Lactose (India) Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, recently experienced a Golden Cross, indicating a potential shift in momentum. Despite a challenging year with a 45.51% decline, the stock has risen 447.21% over five years, outperforming the Sensex significantly.
Why is Lactose (India) falling/rising?
As of 28-Oct, Lactose (India) Ltd's stock price is declining at 114.35, down 0.35%, with a total return of -5.37% over the last three days and a significant year-to-date drop of 47.04%. Despite increased investor interest, the stock remains below key moving averages and lacks positive catalysts for recovery.
Why is Lactose (India) falling/rising?
As of 09-Oct, Lactose (India) Ltd's stock price is Rs 120.00, down 2.87%, and has underperformed its sector by 3.81%. The stock has declined 44.42% year-to-date, with significantly reduced trading volume indicating decreased investor interest.
Lactose (India) Ltd Surges 5.00% Today, Outperforming Sensex Amidst Strong Buying Activity
Lactose (India) Ltd is experiencing notable buying interest, with a significant rise today, outperforming the Sensex. Despite a challenging year-to-date performance, the stock has shown resilience over longer periods, achieving substantial gains over the past five years. Recent developments may be driving this renewed investor interest.
Lactose (India) Faces Financial Challenges Amid Shift to Bearish Outlook
Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation. The company reported flat financial performance for the quarter ending June 2025, with a notable decline in profit after tax and rising interest expenses, raising concerns about cash flow and debt servicing.
How has been the historical performance of Lactose (India)?
Lactose (India) has shown significant growth in net sales, increasing from 34.96 crore in March 2021 to 116.40 crore in March 2025, with profit after tax rising from a loss of 2.48 crore to 5.16 crore during the same period. The company also demonstrated a strong asset base, with total assets reaching 133.47 crore in March 2025.
Why is Lactose (India) falling/rising?
As of 24-Sep, Lactose (India) Ltd's stock price is Rs 127.90, having increased by 1.71% after two days of decline, but with a significant drop in delivery volume. Despite a year-to-date decline of 40.76%, the stock has shown strong long-term growth with increases of 84.56% over three years and 516.39% over five years.
Lactose (India) Faces Financial Challenges Amidst Shift to Sideways Trend
Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score due to changes in the technical landscape. The company reported a flat financial performance for Q1 FY25-26, with a significant decline in profit and rising interest expenses, raising concerns about its debt servicing ability.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
